Beximco Pharmaceauticals Ltd has disclosed its unaudited earnings for the first Quarter (July-September’ 2020).

As per the disclosure,(July-September’ 2020) its earnings per share (EPS) was Tk 2.65 for against one year Tk 2.13

Its net asset value (NAV) per share was tk 82.78

Sunbd/NJ/10:02/11.12.2020